1. Melatonin Prevents Early but Not Delayed Ventricular Fibrillation in the Experimental Porcine Model of Acute Ischemia.
- Author
-
Tsvetkova AS, Bernikova OG, Mikhaleva NJ, Khramova DS, Ovechkin AO, Demidova MM, Platonov PG, and Azarov JE
- Subjects
- Acute Disease, Animals, Cardiac Electrophysiology, Electrophysiological Phenomena, Oxidative Stress, Swine, Ventricular Fibrillation etiology, Ventricular Fibrillation pathology, Central Nervous System Depressants pharmacology, Melatonin pharmacology, Myocardial Ischemia complications, Ventricular Fibrillation prevention & control
- Abstract
Antiarrhythmic effects of melatonin have been demonstrated ex vivo and in rodent models, but its action in a clinically relevant large mammalian model remains largely unknown. Objectives of the present study were to evaluate electrophysiological and antiarrhythmic effects of melatonin in a porcine model of acute myocardial infarction. Myocardial ischemia was induced by 40-min coronary occlusion in 25 anesthetized pigs. After ischemia onset, 12 animals received melatonin (4 mg/kg). 48 intramyocardial electrograms were recorded from left ventricular wall and interventricular septum (IVS). In each lead, activation time (AT) and repolarization time (RT) were determined. During ischemia, ATs and dispersion of repolarization (DOR = RTmax - RTmin) increased reaching maximal values by 3-5 and 20-25 min, respectively. Ventricular fibrillation (VF) incidence demonstrated no relations to redox state markers and was associated with increased DOR and delayed ATs (specifically, in an IVS base, an area adjacent to the ischemic zone) ( p = 0.031). Melatonin prevented AT increase in the IVS base, ( p < 0.001) precluding development of early VF (1-5 min, p = 0.016). VF occurrence in the delayed phase (17-40 min) where DOR was maximal was not modified by melatonin. Thus, melatonin-related enhancement of activation prevented development of early VF in the myocardial infarction model.
- Published
- 2020
- Full Text
- View/download PDF